MCK 맥케슨 · McKesson Corporation

1개월 +14% 급등. 11/4 실적 발표 예정.

종가$1,015.50
시가총액$1,172억
업종헬스케어
다음 실적 발표2026-11-04
PER25.5배
매출 성장(최근 4분기)+8.8%
영업이익률1.6%
애널리스트 순상향률+12%
목표가 상승여력-0.6%
공매도 거래 비중51%
유명 투자자 보유1곳
1년 수익률+29%

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: North American Pharmaceutical, Oncology & Multispecialty, Prescription Technology Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products; delivers products to retail pharmacies, hospitals, long-term care centers, clinics, and institutions; and provides logistics and distribution services for manufacturers. It also provides consulting, out

2026-10-21 기준 · 출처: SEC EDGAR, FINRA, yfinance · 정보 제공용이며 투자 권유가 아닙니다

같은 업종 종목